ARTICLE | Company News
Rademacher, SR Pharma deal
April 2, 2001 7:00 AM UTC
The companies set up a 50-50 joint venture to explore the therapeutic applications of bacterial inositol phosphoglycans (IPGs), which are hormone and growth factor second messengers. Potential disease...